Asthma: Basic Mechanisms and Clinical ManagementPeter J. Barnes, Ian W. Rodger, Neil C. Thomson Elsevier, 20 abr 1998 - 942 páginas Now available in its Third Edition, Asthma: Basic Mechanisms and Clinical Management has become the reference text in asthma. This highly successful text sheds new light on the basic physiological and molecular mechanisms of asthma, how current treatments work, and how best to apply the latest knowledge to control this important disease. The Third Edition has undergone radical revision and includes several new chapters. It retains the virtues of the previous volumes by bringing together all of the recent research findings by internationally recognized experts on the causative mechanisms of asthma, including in-depth clinical aspects and therapy. The book presents an integrated approach toward the treatment of this disease with new concepts, changes in asthma management, and the development of new therapeutic agents. Asthma provides extensive references for researchers and clinicians who need to keep abreast of recent developments in this rapidly expanding field.
|
Índice
35 | |
47 | |
65 | |
Structure and Function | 89 |
Chapter 6 Mast Cells and Basophils | 113 |
Chapter 7 Monocytes Macrophages and Dendritic Cells | 127 |
Chapter 8 Eosinophils | 141 |
Chapter 9 Lymphocytes | 159 |
Chapter 26 Airway Remodelling | 475 |
Chapter 27 Pathophysiology of Asthma | 487 |
Chapter 28 Allergens | 507 |
Chapter 29 Occupational Asthma | 529 |
Chapter 30 Infections | 547 |
Chapter 31 Asthma Provoked by Exercise Hyperventilation and the Inhalation of Nonisotonic Aerosols | 569 |
Chapter 32 Atmospheric Pollutants | 589 |
Chapter 33 Druginduced Asthma | 597 |
Chapter 10 Epithelial Cells | 187 |
Chapter 11 Pathophysiology of Airway Mucus Secretion in Asthma | 205 |
Chapter 12 Tracheobronchial Circulation | 229 |
Chapter 13 Adhesion Molecules | 239 |
Chapter 14 MicrovascularEpithelial Exudation of Plasma | 253 |
Chapter 15 Prostaglandins and Thromboxane | 269 |
Chapter 16 Cysteinyl Leukotrienes | 281 |
Chapter 17 Kinins | 297 |
Chapter 18 Chemokines | 309 |
Color Plate Section | 326 |
Chapter 19 Lymphokines | 329 |
Chapter 20 Other Mediators of Asthma | 343 |
Chapter 21 Nitric Oxide | 369 |
Chapter 22 Neural Control of Airway Function in Asthma | 389 |
Chapter 23 Humoral Control of Airway Tone | 409 |
Chapter 24 NANC Nerves and Neuropeptides | 423 |
Chapter 25 Transcription Factors | 459 |
Chapter 34 Aspirininduced Asthma | 607 |
Chapter 35 Allergen Avoidance | 617 |
Chapter 36 BAdrenoceptor Agonists | 651 |
Chapter 37 Anticholinergic Bronchodilators | 677 |
Chapter 38 Theophylline | 689 |
707 | |
Chapter 40 Glucocorticosteroids | 725 |
Chapter 41 Mediator Antagonists | 767 |
Chapter 42 Immunomodulators | 783 |
Chapter 43 Future Therapies for Asthma | 795 |
Chapter 44 Management of Severe Asthma | 821 |
Chapter 45 Management of Asthma in Adults | 835 |
Chapter 46 Asthma in Children | 859 |
Chapter 47 Pharmacoeconomics of Asthma Treatments | 903 |
Chapter 48 Education and Selfmanagement | 917 |
927 | |
Otras ediciones - Ver todo
Asthma: Basic Mechanisms and Clinical Management Peter J. Barnes,Ian W. Rodger,Neil C. Thomson No hay ninguna vista previa disponible - 1998 |
Términos y frases comunes
activation acute adhesion molecules agonists airway airway hyperresponsiveness airway narrowing airway responsiveness airway smooth muscle allergen Allergy Allergy Clin Immunol antagonists antibody antigen Appl Physiol asthmatic patients asthmatic subjects atopic atopy Barnes PJ bradykinin bronchoconstriction bronchodilator budesonide chemokines cholinergic chronic clinical cytokines disease dose drugs effect endothelial endothelin eosinophil epithelial cells epithelium exposure expression gene glucocorticoids guinea-pig histamine human airways increased induced infection inflammation inhaled corticosteroids inhaled steroids inhibition inhibitors interleukin leukotriene leukotriene D4 lung function lymphocytes macrophages mast cells mechanisms mediators methacholine monocytes mucosal mucus nedocromil nedocromil sodium nerves neuropeptides neutrophil nitric oxide normal oral patients with asthma peptide Pharmacol placebo plasma potent protein pulmonary receptor reduced release Respir Respir Cell Mol Respir Crit Respir Dis 1993 respiratory Rev Respir role salbutamol salmeterol severe asthma smooth muscle ẞ-agonists steroids stimulation studies symptoms T-cell theophylline therapy Thorax tissue tracheal treatment vitro vivo wheezing
Pasajes populares
Página 28 - J 1992; 305:1395-1399. 244. von Mutius E, Martinez FD, Fritzsch C, Nicolai T, Roell G, Thiemann HH. Prevalence of asthma and atopy in two areas of West and East Germany.
Página 60 - Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T: Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis (1985) 131: 599-606.